IRS1 and liver cancer: TAZ has previously been shown to regulate IRS2 expression in liver cancer (Jeong et al., 2018) and to alter insulin sensitivity (El Ouarrat et al., 2020), but we did not observe effects of TAZ on IRS1/2 expression or insulin sensitivity in mice (Figure 2—figure supplement 5).